Spots Global Cancer Trial Database for punch biopsy
Every month we try and update this database with for punch biopsy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Reflectance Confocal Microscopy in Basal Cell Carcinoma | NCT02623101 | Carcinoma, Basa... | Reflectance con... Punch biopsy Surgical excisi... | 18 Years - | Radboud University Medical Center | |
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study | NCT02958462 | Myeloid Maligna... Inherited Bone ... Clonal Expansio... Cytopenia Bone Marrow Fai... Clonal Cytopeni... Clonal Hematopo... Hematologic Neo... Hematopoietic a... Hereditary Neop... Idiopathic Cyto... Idiopathic Dysp... Low Risk Myelod... | Biospecimen Col... Bone Marrow Bio... Punch Biopsy Buccal Swab Clinical Evalua... Genetic Counsel... Quality-of-Life... Electronic Heal... | 18 Years - | Mayo Clinic | |
Genetic Identification (ID) of Segmental Dysplastic Nevi | NCT00955578 | Segmental Dyspl... | Punch Biopsy | 18 Years - | Nova Scotia Health Authority | |
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study | NCT02958462 | Myeloid Maligna... Inherited Bone ... Clonal Expansio... Cytopenia Bone Marrow Fai... Clonal Cytopeni... Clonal Hematopo... Hematologic Neo... Hematopoietic a... Hereditary Neop... Idiopathic Cyto... Idiopathic Dysp... Low Risk Myelod... | Biospecimen Col... Bone Marrow Bio... Punch Biopsy Buccal Swab Clinical Evalua... Genetic Counsel... Quality-of-Life... Electronic Heal... | 18 Years - | Mayo Clinic | |
BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia | NCT04214249 | Acute Myeloid L... Acute Myeloid L... Acute Myeloid L... Secondary Acute... | Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Computed Tomogr... Cytarabine Daunorubicin Hy... Echocardiograph... Hematopoietic C... Idarubicin Hydr... Multigated Acqu... Pembrolizumab Punch Biopsy | 18 Years - 75 Years | National Cancer Institute (NCI) | |
Biopsy Incisional With Trepan in Periocular Lesions | NCT00865813 | Tumor | Punch Biopsy | - | University of Sao Paulo | |
Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome | NCT04652960 | Stage IIB Mycos... Stage III Mycos... Stage IV Mycosi... | Biospecimen Col... Computed Tomogr... Duvelisib Nivolumab Positron Emissi... Punch Biopsy | 18 Years - | National Cancer Institute (NCI) | |
One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy | NCT02285790 | Carcinoma, Basa... | Reflectance con... Punch biopsy Surgical excisi... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
Clinical Diagnosis of Basal Cell Carcinoma Subtype | NCT01370824 | Basal Cell Carc... | Punch biopsy Surgical excisi... | 18 Years - | Maastricht University Medical Center | |
Reflectance Confocal Microscopy in Basal Cell Carcinoma | NCT02623101 | Carcinoma, Basa... | Reflectance con... Punch biopsy Surgical excisi... | 18 Years - | Radboud University Medical Center | |
Reflectance Confocal Microscopy in Basal Cell Carcinoma | NCT02623101 | Carcinoma, Basa... | Reflectance con... Punch biopsy Surgical excisi... | 18 Years - | Radboud University Medical Center | |
Biopsy Incisional With Trepan in Periocular Lesions | NCT00865813 | Tumor | Punch Biopsy | - | University of Sao Paulo | |
Clinical Diagnosis of Basal Cell Carcinoma Subtype | NCT01370824 | Basal Cell Carc... | Punch biopsy Surgical excisi... | 18 Years - | Maastricht University Medical Center | |
(Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC) | NCT03848078 | Basal Cell Carc... Optical Coheren... | Optical Coheren... | 18 Years - | Maastricht University Medical Center | |
Clinical Diagnosis of Basal Cell Carcinoma Subtype | NCT01370824 | Basal Cell Carc... | Punch biopsy Surgical excisi... | 18 Years - | Maastricht University Medical Center | |
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass | NCT01433302 | Breast Cancer Genitourinary C... Malignant Femal... Melanoma Sarcoma | Punch Biopsy | 18 Years - | M.D. Anderson Cancer Center | |
A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments | NCT00586417 | Healthy | punch biopsy | 18 Years - | Duke University | |
One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy | NCT02285790 | Carcinoma, Basa... | Reflectance con... Punch biopsy Surgical excisi... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study | NCT05393713 | Clinical Stage ... Melanoma Metastatic Mela... Recurrent Metas... | Anti-PD-L1 Mono... Punch Biopsy | 18 Years - | Mayo Clinic |